Micvotabart Biosimilar - Research Grade

Human

FN1ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P02751

Blue ice

Fibronectin (FN1) is a large extracellular matrix glycoprotein central to cell adhesion, migration, wound repair, and tissue remodeling, making it a recurring focus in oncology and fibrosis research. This unconjugated, non-therapeutic analog of micvotabart is a recombinant human IgG1 kappa reagent directed against FN1 and intended strictly for research use only (RUO). Purified to a low-endotoxin standard appropriate for in vivo experimentation, it is produced in scalable milligram-to-gram batches that meet the demands of high-throughput and heavy-usage laboratories. Typical work includes matrix-targeting functional assays, in vitro screening, preclinical disease models, and antibody-drug-conjugate development programs.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks